Science
Swiss Study to Prospectively Assess Value of Multi-Omic, Functional Tumor Profiling – Precision Oncology News
The TuPro study will evaluate whether a comprehensive suite of routine and emerging tests can add value to treatment decision making and improve outcomes.
This article has been updated with the number of patients involved in the study and timeline details.
NEW YORK A group of researchers in Switzerland has set out to show the feasibility of incorporating a comprehensive suite of tumor profiling technologies into the treatment decision-making process for cancer patients and prove that such a multi-omics approach will add value over standard approaches and improve precision therapy decisions.
The researchers outlined the design and aims of the Tumor…
-
General22 hours agoAustralian economy still vulnerable to US bond turmoil
-
General8 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business18 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks
-
Noosa News7 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast